Mechanisms of podocyte injury and implications for diabetic nephropathy

• Published in: Clinical science (1979) Vol. 136; no. 7; pp. 493 - 520
• Main Authors: Barutta, Federica, Bellini, Stefania, Gruden, Gabriella
• Format: Journal Article
• Language: English
• Published: England Portland Press Ltd 01.04.2022
• Subjects: Albuminuria - metabolism; Autophagy; Diabetes & Metabolic Disorders; Diabetes Mellitus - metabolism; Diabetic Nephropathies - metabolism; Glomerulosclerosis, Focal Segmental - metabolism; Humans; Podocytes - metabolism; Review; podocytes; proteinuria; diabetic nephropathy
• ISSN: 0143-5221; 1470-8736; 1470-8736
• DOI: 10.1042/CS20210625

Albuminuria is the hallmark of both primary and secondary proteinuric glomerulopathies, including focal segmental glomerulosclerosis (FSGS), obesity-related nephropathy, and diabetic nephropathy (DN). Moreover, albuminuria is an important feature of all chronic kidney diseases (CKDs). Podocytes play a key role in maintaining the permselectivity of the glomerular filtration barrier (GFB) and injury of the podocyte, leading to foot process (FP) effacement and podocyte loss, the unifying underlying mechanism of proteinuric glomerulopathies. The metabolic insult of hyperglycemia is of paramount importance in the pathogenesis of DN, while insults leading to podocyte damage are poorly defined in other proteinuric glomerulopathies. However, shared mechanisms of podocyte damage have been identified. Herein, we will review the role of haemodynamic and oxidative stress, inflammation, lipotoxicity, endocannabinoid (EC) hypertone, and both mitochondrial and autophagic dysfunction in the pathogenesis of the podocyte damage, focussing particularly on their role in the pathogenesis of DN. Gaining a better insight into the mechanisms of podocyte injury may provide novel targets for treatment. Moreover, novel strategies for boosting podocyte repair may open the way to podocyte regenerative medicine.